Page 30 - Layout 1
P. 30

CDC EXECUTIVE                                                                                                                                                                                                   CDC EXECUTIVE
            SUMMARY                                                                                                                                                                                                         SUMMARY







                                                                                                                                                                       the G614 variant spreads more quickly   What is CDC doing to track emerging
                                                                                                                                                                       than viruses without the mutation.   variants of SARS-CoV-2?

                  Centers for Disease Control                                                                                                                        •  Ability to cause either milder or more se-  launched the National SARS-CoV-2 Strain
                                                                                                                                                                                                            In November 2020, CDC officially
                                                                                                                                                                       vere disease in humans. There is no evi-
                                                                                                                                                                       dence that VOC 202012/01 produces   Surveillance (NS3) program to increase the
           Implications of the Emerging SARS-CoV-2 Variant VOC 202012/01                                                                                               more severe illness than other SARS-CoV-  number and representativeness of viruses un-
                                                                                                                                                                       2 variants.                        dergoing characterization. When fully imple-

                                              Updated December 22, 2020                                                                                                                                   mented in January 2021, each state will send
                                                                                                                                                                     •  Ability to evade detection by specific diag-
                                                                                                                                                                                                          CDC at least 10 samples biweekly for se-
                                                                                                                                                                       nostic tests. Most commercial polymerase
                                                                                                                                                                                                          quencing and further characterization. In ad-
                                                                                                                                                                       chain reaction (PCR) tests have multiple
                                                                                                                                                                                                          dition, CDC’s COVID-19 response is
                                                                                                                                                                       targets to detect the virus, such that even
                                                                                                                                                                                                          actively seeking samples of interest, such as
                                                                                                                                 they are “non-synonymous”), but this amino   if a mutation impacts one of the targets,
        Executive summary                    Why has this variant been in the    the United Kingdom and the United States,                                                                                samples associated with animal infection

          A new variant strain of SARS-CoV-2 that   news recently?               as well as the high prevalence of this variant   acid substitution does not impact the pro-  the other PCR targets will still work.   and, in the future, samples from vaccine-
                                                                                                                                 tein’s function.
        contains a series of mutations has been de-  Since November 2020, a variant strain of   among current UK infections, increase the                            •  Decreased susceptibility to therapeutic   breakthrough infections. Data from these ef-
                                                                                                                                   VOC 202012/01 has 14 non-synonymous
        scribed in the United Kingdom (UK) and   SARS-CoV-2 has become prevalent in the   likelihood of importation. Given the small                                   agents such as monoclonal antibodies.   forts are continuously analyzed at CDC, and

                                                                                                                                 (amino acid [AA] altering) mutations, 6 syn-
        become highly prevalent in London and   southeast of England, reportedly accounting   fraction of US infections that have been se-                           •  Ability to evade vaccine-induced immu-  genomic data are rapidly uploaded to public
                                                                                                                                 onymous (non-AA altering), and 3 deletions,
        southeast England. Based on these muta-  for 60% of recent infections in London. This   quenced, the variant could already be in the                           nity. FDA-authorized vaccines are “poly-  databases for use by researchers, public health
                                                                                                                                 notably including,
        tions, this variant strain has been predicted   variant has a mutation in the receptor bind-  United States without having been detected.                      clonal,” producing antibodies that target   agencies, and industry. To coordinate US se-
        to potentially be more rapidly transmissible   ing domain (RBD) of the spike protein at po-                              •  69/70 deletion: this double deletion has   several parts of the spike protein. The virus   quencing efforts outside of CDC, since early
        than other circulating strains of SARS-CoV-  sition 501, where amino acid asparagine (N)   What do we know already about    occurred spontaneously many times, and   would likely need to accumulate multiple   in the pandemic, CDC has led a national
        2. Although a variant may predominate in a   has been replaced with tyrosine (Y). The   variants containing N501Y?         likely leads to a change in the shape of (i.e.,   mutations in the spike protein to evade im-  coalition of laboratories sequencing SARS-
        geographic area, that fact alone does not   shorthand for this mutation is N501Y, some-  Prior work on variants with N501Y sug-  a conformational change in) the spike pro-  munity induced by vaccines or by natural   CoV-2 (SPHERES). The SPHERES coali-
        mean that the variant is more infectious. Sci-  times noted as S:N501Y to specify that it is   gests they may bind more tightly to the   tein.                 infection.                         tion consists of more than 160 institutions,

        entists are working to learn more about this   in the spike protein. This variant carries many   human angiotensin-converting enzyme 2   •  P681H: near the S1/S2 furin cleavage site,            including academic centers, industry, non-
        variant to better understand how easily it   other mutations, including a double deletion   (ACE2) receptor. It is unknown whether   a site with high variability in coron-  Among these possibilities, the last—the   governmental organizations, and public
        might be transmitted and whether currently   (positions 69 and 70).      that tighter binding, if true, translates into    aviruses. This mutation has also emerged   ability to evade vaccine-induced immunity—  health agencies. Of the approximately
        authorized vaccines will protect people                                  any significant epidemiological or clinical       spontaneously multiple times.     would likely be the most concerning because   275,000 full-genome sequences currently in
        against it. At this time, there is no evidence   Why has this variant emerged    differences. In one laboratory study of trans-                              once a large proportion of the population is   public databases, 51,000 are from the United
        that this variant causes more severe illness or   in the UK?             mission of the virus between ferrets, this mu-  •  ORF8 stop codon (Q27stop): This muta-  vaccinated, there will be immune pressure   States. (The UK currently has the most se-
        increased risk of death. Information regard-  We do not know. By chance alone, viral   tation (and one other) spontaneously arose   tion is not in the spike protein but in a dif-  that could favor and accelerate emergence of   quences, with 125,000).
        ing the virologic, epidemiologic, and clinical   variants often emerge or disappear, and   in the ferrets during the experiment. The sig-  ferent gene (in open reading frame 8), the   such variants by selecting for “escape mu-
        characteristics of the variant are rapidly   that may be the case here. Alternatively, it   nificance of this observation remains to be   function of which is unknown. Similar   tants.” There is no evidence that this is occur-  Last Updated Dec. 22, 2020
        emerging. CDC, in collaboration with other   may be emerging because it is better fit to   elucidated. VOC 202012/01 so far has no   mutations have occurred in the past. In   ring, and most experts believe escape mutants   Content source: National Center for Im-
        public health agencies, is monitoring the sit-  spread in humans. This rapid change from   known association with animals or animal   Singapore, one strain with this type of mu-  are unlikely to emerge because of the nature   munization and Respiratory Diseases
        uation closely. CDC will communicate new   being a rare strain to becoming a common   contact.                             tation emerged and disappeared.   of the virus.                        (NCIRD), Division of Viral Diseases
        information as it becomes available.   strain has concerned scientists in the UK,
                                             who are urgently evaluating the characteris-  What about the other mutations in     What implications could the         Is this new variant related to the newly
        Does this variant have a name?       tics of the variant strain and of the illness that   this variant of SARS-CoV-2?    emergence of new variants have?     emergent variant in South Africa?
          At present, the variant is referred to as   it causes.                   SARS-CoV-2 mutates regularly, acquiring         Among the potential consequences of   On December 18, 2020, the South African
        “SARS-CoV-2 VOC 202012/01” (i.e., the                                    about one new mutation in its genome every      these mutations are the following:   government announced that it had also seen
        first variant of concern from 2020, December),   Have we seen this variant in    two weeks. Many mutations are silent (i.e.,   •  Ability to spread more quickly in hu-  the emergence of a new strain in a scenario
        or “B.1.1.7.” The press often uses the terms   the United States?        cause no change in the structure of the pro-      mans. There is already evidence that one   similar to that in the UK. The South African
        “variant,” “strain,” “lineage,” and “mutant” in-  The VOC 202012/01 variant has not been   teins they encode) because they produce a   mutation, D614G, has this property to   variant also has the N501Y mutation and
        terchangeably. For the time being in the con-  identified through sequencing efforts in the   three-letter codon that translates to the same   spread more quickly. In the lab, G614 vari-  several other mutations but emerged com-
        text of this variant, the first three of these terms   United States, although viruses have only   amino acid (i.e., they are “synonymous”).   ants propagate more quickly in human res-  pletely independently of the UK strain and
        are generally being used interchangeably by the   been sequenced from about 51,000 of the 17   Other mutations may change the codon in a   piratory epithelial cells, out-competing   is not related to it.
        scientific community as well.        million US cases. Ongoing travel between   way that leads to an amino acid change (i.e.,   D614 viruses. There also is evidence that



         30     SAN ANTONIO MEDICINE  • January 2021                                                                                                                                                                 Visit us at www.bcms.org     31
   25   26   27   28   29   30   31   32   33   34   35